Condition
Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownPhase II Study of RC1416 Injection in COPDNCT07402551 · 2026-03-06
RECRUITINGActive Cycle Of Breathing Technique And Pursed Lip Breathing in Moderate to Severe COPD PatientsNCT07742033 · 2025-01-11
COMPLETEDStudy to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).NCT06175351 · 2023-07-06
ACTIVE_NOT_RECRUITINGPhase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPDNCT01584505 · 2012-04-01
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED2
ACTIVE_NOT_RECRUITING1
RECRUITING1
Phase mix
PHASE23
NA1
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.